Close Menu

SAN FRANCISCO – Bay Area startup Nephrosant, a University of California, San Francisco spinout, aims to launch its first noninvasive test for detecting kidney injury by early next year.

Nephrosant, formerly known as KIT Bio, has around 10 employees and has raised about $3 million in seed financing, said Minnie Sarwal, the company's cofounder and a professor of surgery at UCSF. The company plans to start a Series A financing round next year.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.